Similar Articles |
|
Chemistry World February 26, 2008 James Mitchell Crow |
Q and A: Do Antidepressants Work? A widely-reported analysis of clinical trial data for Prozac and related antidepressant drugs has claimed that the medicines work little better than chemically-inactive placebos in all but the most severely depressed patients. |
Chemistry World March 4, 2008 Rebecca Trager |
Controversy Over EPA Removal of Top Toxicologist The US Environmental Protection Agency (EPA) is being accused of caving to pressure from the chemical industry after dismissing Deborah Rice from a scientific review panel following protests from the American Chemistry Council. |
The Motley Fool March 29, 2010 Brian Orelli |
Look for Companies That Strike First Head-to-head trials, whether they're run by companies or by third parties, can be scary. But the way to make big money is by selling drugs that offer superior benefits, so investors should welcome the onslaught of upcoming comparative trial data. |
Chemistry World October 3, 2012 Ian Le Guillou |
Health check finds Canadian science doing well Canadian science is healthy and growing, according to an independent expert panel at the Council of Canadian Academies |
Chemistry World April 2008 Derek Lowe |
Column: In the Pipeline The recent row over antidepressants reminds us how little we know about the brain. |
The Motley Fool August 31, 2009 Brian Orelli |
Don't Let Dummy Pills Make You a Dummy Investor Instead of being scared that the sugar pill will perform better than expected, pharma investors should factor it in and require more information before investing in companies with drugs that may be affected by it.. |
Chemistry World September 11, 2007 Rebecca Trager |
EPA Counters Industry Funding Criticism The US Environmental Protection Agency is defending its growing practice of jointly funding research with industry, after lobby groups voiced concerns that the agency's science is being compromised. |
The Motley Fool January 3, 2011 Brian Orelli |
Clinical Trial Results Fail to Inspire Inspire Pharma gets cut in half after a cystic fibrosis trial failure. |
Chemistry World April 18, 2008 Rebecca Trager |
EPA probes its own dismissal of scientist The US Environmental Protection Agency (EPA) has launched an internal enquiry on its decision to remove toxicologist Deborah Rice from an internal review panel last summer, amid a congressional enquiry on the issue. |
Chemistry World February 11, 2010 Anna Lewcock |
Science advice rules could do more harm than good Eminent UK scientists have raised concerns that recent moves to ensure the independence of scientific advice in government may in fact further threaten the relationship between the two communities. |
Chemistry World November 2011 |
Reaching out The explosion is the doyenne of chemical demonstrations, but is the web taking over as a tool for researchers to enthuse the public about chemistry? Success online depends on reaching the right audience. YouTube and iTunes make this easier |
Chemistry World April 25, 2008 Rebecca Trager |
Environmental Scientists Report Political Interference Hundreds of the US Environmental Protection Agency's scientific staff have experienced political interference in their work, a survey has revealed. |
The Motley Fool January 25, 2011 Brian Orelli |
FDA Approved -- Now Will It Sell? There's still plenty of uncertainty in Clinical Data's shares. |
Wired August 24, 2009 Steve Silberman |
Placebos Are Getting More Effective. Drugmakers Are Desperate to Know Why. The fact that taking a faux drug can powerfully improve some people's health -- the so-called placebo effect -- has long been considered an embarrassment to the serious practice of pharmacology. |
Chemistry World June 13, 2011 Rebecca Trager |
EPA discloses confidential chemical information The US Environmental Protection Agency has made public company data on over 150 chemicals used in more than 100 health and safety studies. |